Circular RNAs as a novel molecular mechanism in diagnosis, prognosis, therapeutic target, and inhibiting chemoresistance in breast cancer
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2024.155569 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Nafiseh Tashakori und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Faculty of Internal Medicine,Tehran Branch, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: RNA, Circular, Breast Neoplasms, Drug Resistance, Neoplasm, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 217 Literaturangaben.
Abstract (Originalsprache)
Breast cancer (BC) is the most common cancer among women, characterized by significant heterogeneity. Diagnosis of the disease in the early stages and appropriate treatment plays a crucial role for these patients. Despite the available treatments, many patients due to drug resistance do not receive proper treatments. Recently, circular RNAs (circRNAs), a type of non-coding RNAs (ncRNAs), have been discovered to be involved in the progression and resistance to drugs in BC. CircRNAs can promote or inhibit malignant cells by their function. Numerous circRNAs have been discovered to be involved in the proliferation, invasion, and migration of tumor cells, as well as the progression, pathogenesis, tumor metastasis, and drug resistance of BC. Circular RNAs can also serve as a biomarker for diagnosing, predicting prognosis, and targeting therapy. In this review, we present an outline of the variations in circRNAs expression in various BCs, the functional pathways, their impact on the condition, and their uses in clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Faculty of Internal Medicine,Tehran Branch, Islamic Azad University, Tehran, Iran.
- Department of Prosthetic Dentistry, I.M. Schenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
- College of Pharmacy, Alnoor University, Mosul, Iraq.
- College of MLT, Ahl Al Bayt University, Iraq.
- Gilgamesh Ahliya University, Baghdad, Iraq.
- Collage of Pharmacy, National University of Science and Technology, Dhi Qar 64001, Iraq.
Zitieren
APA
Tashakori, N., Mikhailova, M. V., Mohammedali, Z. A., Mahdi, M. S., Ali Al-Nuaimi, A. M., Radi, U. K., Alfaraj, A. M., & Kiasari, B. A. (2024). Circular RNAs as a novel molecular mechanism in diagnosis, prognosis, therapeutic target, and inhibiting chemoresistance in breast cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155569
Vancouver
Tashakori N, Mikhailova MV, Mohammedali ZA, Mahdi MS, Ali Al-Nuaimi AM, Radi UK, et al. Circular RNAs as a novel molecular mechanism in diagnosis, prognosis, therapeutic target, and inhibiting chemoresistance in breast cancer. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155569
BibTeX
@article{Tashakori2024,
author = {Tashakori, Nafiseh and Mikhailova, Maria V and Mohammedali, Zainab Abbas and Mahdi, Morug Salih and Ali Al-Nuaimi, Ali M and Radi, Usama Kadem and Alfaraj, Abdullateff Mohammad and Kiasari, Bahman Abedi},
title = {Circular RNAs as a novel molecular mechanism in diagnosis, prognosis, therapeutic target, and inhibiting chemoresistance in breast cancer},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2024.155569}
}
EUVIMED